BANK OF MONTREAL /CAN/ - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 15 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$694,000
-29.3%
142,846
+36.7%
0.00%
-100.0%
Q1 2021$982,000
+28.5%
104,524
+27.7%
0.00%0.0%
Q4 2020$764,000
+76300.0%
81,882
+26313.5%
0.00%
Q3 2020$1,000
-50.0%
3100.0%0.00%
Q2 2020$2,000
+100.0%
3100.0%0.00%
Q1 2020$1,000
-50.0%
3100.0%0.00%
Q4 2019$2,000
+100.0%
3100.0%0.00%
Q3 2019$1,000
-50.0%
3100.0%0.00%
Q2 2019$2,000
+100.0%
3100.0%0.00%
Q1 2019$1,0003100.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,146,470$4,861,0005.06%
Corriente Advisors, LLC 730,000$3,095,0001.57%
Manatuck Hill Partners, LLC 571,500$2,423,0001.11%
CVI Holdings, LLC 276,176$1,171,0000.48%
DAFNA Capital Management LLC 156,529$664,0000.22%
Worth Venture Partners, LLC 42,887$182,0000.15%
Granite Point Capital Management, L.P. 646,855$2,743,0000.15%
Ikarian Capital, LLC 415,000$1,759,0000.13%
Maven Securities LTD 359,285$1,473,0000.12%
Nantahala Capital Management 756,193$3,206,0000.10%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders